Applied Dna Sciences (NASDAQ:BNBX) Releases Earnings Results

Applied Dna Sciences (NASDAQ:BNBX) issued its quarterly earnings data on Friday. The company reported ($0.68) earnings per share for the quarter, Zacks reports.

Applied Dna Sciences Stock Performance

Applied Dna Sciences stock opened at $0.44 on Friday. The firm has a market cap of $2.49 million, a PE ratio of 0.00 and a beta of 0.58. The firm’s 50-day moving average is $0.62. Applied Dna Sciences has a 52 week low of $0.44 and a 52 week high of $12.09.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Applied Dna Sciences in a research report on Friday, April 24th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

Applied Dna Sciences Company Profile

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.